imidazole has been researched along with glucagon-like peptide 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bode, HP; Göke, B; Göke, R; Hareter, A; Hoffmann, E | 1 |
| Agarwal, S; Bhayani, H; Deshmukh, P; Giri, P; Giri, S; Jain, M; Kulkarni, N; Kumar, J; Sasane, S; Soman, S | 1 |
2 other study(ies) available for imidazole and glucagon-like peptide 1
| Article | Year |
|---|---|
The positive charge of the imidazole side chain of histidine7 is crucial for GLP-1 action.
Topics: Animals; Binding, Competitive; Cricetinae; DNA, Complementary; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Histidine; Imidazoles; Peptide Fragments; Protein Precursors; Rats; Receptors, Glucagon; Signal Transduction; Transfection | 1997 |
Evaluation of novel TGR5 agonist in combination with Sitagliptin for possible treatment of type 2 diabetes.
Topics: Animals; Binding Sites; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucagon-Like Peptide 1; Half-Life; Humans; Hypoglycemic Agents; Imidazoles; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Structure, Tertiary; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Structure-Activity Relationship | 2018 |